The role of the gut microbiome in the progression of Parkinson’s disease: a systematic review of patient cohorts
Abstract
Parkinson’s disease (PD) is the second most common neurodegenerative disease. The etiology of PD is not yet fully understood. In recent years, the role of the gut microbiome in the progression of the disease came to attention. A deeper understanding of the relationship between the gut microbiome and the development and progression of PD may innovate therapeutic approaches. The aim of the present literature analysis is to systematically evaluate alterations in gut microbiome in PD and its correlation with clinical symptoms. A search for publications via PubMed using the search terms “Parkinson’s disease” AND “gut microbiome” AND “human” was performed. The main inclusion criteria were a subject number ≥ 30 per group, patients with clinically confirmed PD, an analysis of the gut microbiome in a case–control, cross-sectional or longitudinal study design. The evaluation of the results showed that gut microbiome of PD patients is altered both in early stages of the disease and throughout its progression compared to healthy controls. These alterations correlate with clinical symptoms. In general, the diversity of micro-organisms in the gut is reduced in PD patients, and the composition of the gut microbiome differs significantly from healthy persons. Particularly a reduction in short-chain fatty acid (SCFA) producing genera such as Faecalibacterium and Roseburia and the increase in pro-inflammatory taxa such as Collinsella and Akkermansia is described. According to current…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids
- Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome
- Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease
- Diet, obesity, and the gut microbiome as determinants modulating metabolic outcomes in a non-human primate model
- Immune Impairment Associated with Vitamin A Deficiency: Insights from Clinical Studies and Animal Model Research
- Glyphosate-based herbicides influence antioxidants, reproductive hormones and gut microbiome but not reproduction: A long-term experiment in an avian model
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.